Quantum computing is emerging as a transformative approach in bioinformatics and quantum chemistry, addressing fundamental computational limitations of classical methods in molecular science. Many biological and chemical systems are inherently governed by quantum mechanics, making accurate simulation with classical algorithms computationally expensive or infeasible. This review examines how quantum computing, particularly in the Noisy Intermediate-Scale Quantum (NISQ) era, is advancing molecular modeling, reaction dynamics, and bioinformatics applications. Key quantum algorithms, including the Variational Quantum Eigensolver (VQE) and Quantum Phase Estimation (QPE), demonstrate increasing capability in approximating molecular energies and simulating quantum systems. In parallel, applications in bioinformatics—such as protein folding, genomic search, and combinatorial optimization—highlight the potential of quantum computing to address complex biological problems. Quantum machine learning further extends these capabilities by integrating quantum algorithms with data-driven modeling. However, current progress is constrained by NISQ-era limitations, including noise, limited qubit counts, and scalability challenges. These constraints highlight the need for hybrid quantum–classical approaches and improved error mitigation strategies. Overall, quantum computing represents a complementary computational paradigm that can enhance classical methods in bioinformatics and chemistry. Continued advances in quantum algorithms, hardware, and hybrid modeling frameworks are expected to expand its role in molecular science and computational biology.
Quantum computing is emerging as a transformative approach in bioinformatics and quantum chemistry, addressing fundamental computational limitations of classical methods in molecular science. Many biological and chemical systems are inherently governed by quantum mechanics, making accurate simulation with classical algorithms computationally expensive or infeasible. This review examines how quantum computing, particularly in the Noisy Intermediate-Scale Quantum (NISQ) era, is advancing molecular modeling, reaction dynamics, and bioinformatics applications. Key quantum algorithms, including the Variational Quantum Eigensolver (VQE) and Quantum Phase Estimation (QPE), demonstrate increasing capability in approximating molecular energies and simulating quantum systems. In parallel, applications in bioinformatics—such as protein folding, genomic search, and combinatorial optimization—highlight the potential of quantum computing to address complex biological problems. Quantum machine learning further extends these capabilities by integrating quantum algorithms with data-driven modeling. However, current progress is constrained by NISQ-era limitations, including noise, limited qubit counts, and scalability challenges. These constraints highlight the need for hybrid quantum–classical approaches and improved error mitigation strategies. Overall, quantum computing represents a complementary computational paradigm that can enhance classical methods in bioinformatics and chemistry. Continued advances in quantum algorithms, hardware, and hybrid modeling frameworks are expected to expand its role in molecular science and computational biology.
However, accurately simulating molecular interactions constitutes the central, but open question of computer chemistry. This is a core task for efforts in drug development, catalyst design, and materials science. Most classical algorithms perform well on smaller systems, but incumbent exponential scaling penalties are unavoidable as models grow larger and more complex to describe quantum behaviour. An entirely new paradigm for this problem is now introduced by quantum computing: superposition and entanglement resources natively encode quantum states and model their electronic structures. The paper will thus take a high-level view of the leading quantum algorithms, with particular regard to those called Variational Quantum Eigensolver (VQE) and Quantum Phase Estimation (QPE), while evaluating their performance on today's Noisy Intermediate Scale Quantum (NISQ) devices. Next will follow discussions on algorithm design and current hardware capabilities, before which open challenges on scalability, error mitigation, and algorithm design will be outlined. Emphasis shall also be placed on the ethics and accessibility issues as well as the timelines with which quantum computing might gain a practical advantage. Linking together the recent advances and limitations, this paper posits how quantum computer implementation may change the face of chemical modelling and scientific discovery.
Quantum chemistry plays a crucial role in advancing fundamental understanding of chemical processes and driving innovation in energy, medicine, and materials science. Recent progress in quantum computing has opened new possibilities for molecular simulations that are beyond the practical limits of classical approaches. Academic studies have demonstrated hybrid Density Functional Theory (DFT) and Variational Quantum Eigensolver (VQE) benchmarks on small transition-metal systems, such as iron porphyrin and heme analogues, using current noisy intermediate-scale quantum (NISQ) hardware. Although full-scale simulations of complex biological systems such as the complete Cytochrome P450 (CYP450) active site remain a long-term goal due to limitations in qubit numbers, coherence times, and error correction, the underlying methodologies are now well established. At present, quantum chemistry applications in drug discovery remain largely experimental, and widespread practical medical impact is expected to require further technological advances over the next 5–10 years. Nevertheless, quantum software and algorithm development for chemical applications is progressing rapidly. This perspective summarizes recent advances in quantum computing algorithms, hardware, and software relevant to chemistry, and critically discusses the remaining challenges and opportunities for applying quantum computing to chemical problems, with particular emphasis on drug discovery and development.
This paper investigates the potential advantages of employing quantum computing in the field of bioinformatics to advance precision medicine. It explores the current understanding, tools, and algorithms associated with quantum computing, with a specific focus on quantum simulations for molecular modeling, quantum machine learning for pattern recognition in complex biological data, and quantum optimization for solving challenges in protein folding, genetic optimization, and metabolic pathway engineering. By leveraging quantum computing, more accurate insights into biochemical reactions and improved drug design strategies can be achieved. Additionally, the application of quantum machine learning algorithms holds promise for advancements in genomics, proteomics, and personalized medicine.
Quantum chemistry has experienced transformative advancements from 2010 to 2024, propelled by developments in quantum computing, machine learning, and computational methodologies. These innovations have enabled precise simulations of complex molecular systems, fostering significant progress in materials science, drug discovery, and energy research. The integration of quantum computing has introduced algorithms like the Variational Quantum Eigensolver (VQE), facilitating the calculation of molecular ground-state energies. Machine learning techniques have enhanced predictive modeling, optimizing chemical reactions and material properties. Additionally, the development of user-friendly quantum chemistry software has democratized access to sophisticated computational tools. Despite these advancements, challenges such as scalability, error mitigation in quantum computations, and the need for high-quality data persist. Addressing these issues is crucial for the continued evolution of quantum chemistry, promising transformative impacts on technology and society.
Bioinformatics workloads -- including protein structure prediction, molecular dynamics simulation, genomic sequencealignment, and phylogenetic tree reconstruction -- are among the most computationally intensive problems in science,with many exhibiting exponential or combinatorial scaling that overwhelms classical high-performance computing.Quantum computing, leveraging superposition and entanglement to explore exponentially large solution spaces,promises polynomial or exponential speedups for specific bioinformatics tasks. However, current noisyintermediate-scale quantum (NISQ) devices (50-1,000+ qubits, high error rates) are far from fault-tolerant quantumcomputers, and the practical quantum advantage for bioinformatics remains undemonstrated. This study systematicallybenchmarked five computational approaches -- classical exact algorithms, classical heuristics (genetic algorithm,simulated annealing), GPU-accelerated methods, variational quantum algorithms (VQE, QAOA) on NISQ hardware, anda proposed hybrid quantum-classical bioinformatics pipeline (HQC-Bio) combining quantum subroutines for combinatorialsubproblems with classical pre/post-processing -- across four bioinformatics tasks: multiple sequence alignment (MSA, n= 500 protein families), protein folding on lattice models (HP model, chains 20-60 residues), molecular docking scoring(1,000 ligand-receptor pairs), and phylogenetic tree search (taxa sets 10-50). HQC-Bio achieved the highest solutionquality for protein folding (optimal energy found in 84.6% of 40-residue instances vs 62.4% for simulated annealing; p <0.001) and phylogenetic search (log-likelihood within 0.2% of exact ML for 30-taxa trees vs 1.8% for RAxML heuristic).However, quantum wall-clock time exceeded classical GPU by 12-340x due to NISQ hardware overhead (circuitcompilation, shot noise, error mitigation), establishing that current quantum advantage is in solution quality rather thanspeed. Resource estimation projects that fault-tolerant quantum computers with 10,000-100,000 logical qubits couldachieve genuine speedups of 10-1,000x for these tasks within 10-15 years.
Accurate prediction of molecular structures and properties is vital for chemistry; materials science, and drug discovery, yet classical electronic-structure methods often fail for strongly correlated systems, large basis sets, and complex potential-energy landscapes. Quantum technology encompassing quantum computing, quantum machine learning, and hybrid quantum classical strategies offers a fundamentally new paradigm by encoding many-electron wave functions directly on qubits and exploiting superposition and entanglement to explore exponentially large Hilbert spaces. This review synthesizes recent algorithmic and hardware advances relevant to molecular modelling, including the Variational Quantum Eigensolver (VQE), Quantum Phase Estimation (QPE), quantum unitary coupled-cluster (q-UCC) families, equation-of-motion and subspace methods for excited states, tensor-network hybrids, and quantum kernel and variational QML approaches. We examine noise-aware hybrid workflows, error-mitigation techniques, symmetry-preserving ansätze, and operator-factorization methods that reduce measurement and gate overhead. Representative applications are discussed: ground- and excited-state energy prediction, potential-energy surface mapping, geometry and transition-state optimization, spectroscopic property estimation (IR, UV–Vis, NMR, EPR), and reaction-dynamics scenarios where non-adiabatic effects and conical intersections dominate. Resource estimates and scaling analyses clarify current NISQ limitations qubit counts, circuit depth, shot complexity and delineate the roadmap to fault-tolerant QPE for chemical accuracy. We compare quantum approaches with classical baselines (DFT, CCSD (T), multireference methods), identifying domains where quantum methods already show promise (strong correlation, multi-reference dissociation, spin-state ordering) and where classical methods remain competitive. Finally, we highlight near-term industrial opportunities in drug design, catalysis, CO2 capture, and energy materials, and outline critical research directions: algorithmic reductions in measurement/precision cost, hardware improvements in fidelity and connectivity, scalable ansatz design, and integrated software stacks for reproducible hybrid simulations. Together, these developments indicate that while practical, large-scale quantum advantage for general chemistry remains future work, quantum technologies are rapidly maturing into powerful tools for targeted molecular problems that are intractable with existing classical techniques.